Delivery Order HT942523D0016-HT942524F0225

Award Date 9/13/24
Potential Completion Date 10/15/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
This federal contract award, valued at $14,992.34, was issued by the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The contract is a firm-fixed-price purchase order for the provision of various reagents and E-test kits, which are specialized diagnostic products for infectious disease testing and pathogen detection. The contract does not have a set-aside designation, indicating that Biomerieux Inc. is likely considered a...
The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a microbiology analyzer and consumables. The $87,980.77 contract has an ultimate completion date of December 16, 2022. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole awardee and is not subject to any set-aside designations. The company is known for its proprietary diagnostic platforms, such as VITEK,...
The U.S. government's Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a global leader in in vitro diagnostics, for the procurement of BioMérieux test kits and reagents. The $16,081.23 firm-fixed-price contract has an ultimate completion date of October 18, 2022. Biomerieux Inc., through its Biomerieux, Inc. Division, specializes in microbiological testing solutions for medical, food safety, and...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, by the Defense Health Agency. The contract, awarded on October 1, 2017, is for the provision of reagents and consumables supplies such as test kits, with a ceiling value of $75,000.00. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and has an ultimate completion date of September 30, 2018. The place of performance is Bethesda, MD. Biomerieux Inc. is a...
This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract, valued at $125,000.00, is for the delivery of reagents with a period of performance ending on September 30, 2015. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial applications. The company provides...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of reagents compatible with the BioMerieux VITEK 2 Compact 30 system. The $95,083 firm-fixed-price delivery order was awarded by the Defense Health Agency, a component of the Department of Defense, under the Scientific Equipment and Services Federal Supply Schedule contract. The contract does not involve any set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division,...
This firm-fixed-price delivery order was awarded by a U.S. government agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of its proprietary BioMerieux products. The $56,200 contract is for BioMerieux's specialized clinical diagnostic equipment, reagents, and supplies, including automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The award was made under Biomerieux's Federal Supply...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This is a firm-fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $16,879.50, is for the provision of Biomerieux's proprietary diagnostic platforms, reagents, and test kits to support the agency's infectious disease testing and pathogen detection requirements. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized...
  • HT942523D0016
    Indefinite Delivery Contract
  • HT942523D0016-HT942524F0225
    Delivery Order

This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024.

Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs, Defense, Agriculture, and Health and Human Services. The company's core offerings include automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. This contract does not involve a set-aside designation, as Biomerieux is often the sole source provider for its proprietary technologies.

The award is associated with Biomerieux's existing federal contract Indefinite Delivery Vehicles (IDVs), including a $194 million Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, as well as Blanket Purchase Agreements with the Department of Veterans Affairs and the Indian Health Service. These IDVs allow various government agencies to efficiently access Biomerieux's diagnostic solutions through task orders for products and services.

Generated 2/19/25, 9:11 AM